{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:55:53Z","timestamp":1768200953324,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jbspin.2017.12.001","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:21Z","timestamp":1513123221000},"page":"365-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures"],"prefix":"10.1016","volume":"85","author":[{"given":"Morgane","family":"Righetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Wach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Desmarchelier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Coury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2017.12.001_bib0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1759720X11416270","article-title":"Atypical femur fractures: a review of the evidence and its implication to clinical practice","volume":"3","author":"Girgis","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/SPC.0b013e3283552d7d","article-title":"Atypical femoral fractures: epidemiology, etiology, and patient management","volume":"6","author":"Donnelly","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bone.2013.07.010","article-title":"Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy","volume":"56","author":"Franceschetti","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.02.006","article-title":"Symptomatic atypical femoral fractures are related to underlying hip geometry","volume":"63","author":"Taormina","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0090","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2106\/JBJS.K.01181","article-title":"Bisphosphonates and non-healing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project","volume":"95","author":"Edwards","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jbspin.2015.10.009","article-title":"Atypical femoral fracture in a 51-year-old woman: revealing a hypophosphatasia","volume":"83","author":"Maman","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12891-016-1191-8","article-title":"Hypophosphatasia and the risk of atypical femur fractures: a case-control study","volume":"17","author":"Bhattacharyya","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbrc.2012.06.106","article-title":"Effects of intermittent versus continuous parathyroid hormone administration on condylar chondrocyte proliferation and differentiation","volume":"424","author":"Liu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4158\/EP15890.OR","article-title":"Adult hypophosphatasia treated with teriparatide: report of two patients and review of the literature","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0120","first-page":"266","article-title":"Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report","volume":"6","author":"Doshi","year":"2009","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jc.2009-1965","article-title":"Lack of sustained response to teriparatide in a patient with adult hypophosphatasia","volume":"95","author":"Gagnon","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2017.12.001_bib0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40265-015-0535-2","article-title":"Asfotase alfa: a review in paediatric-onset hypophosphatasia","volume":"76","author":"Scott","year":"2016","journal-title":"Drugs"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17302063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17302063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T08:56:39Z","timestamp":1535187399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X17302063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1297319X17302063"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.12.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}